The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial
EuroIntervention 2018;14:86-93 published online March 2018. DOI: 10.4244/EIJ-D-17-00890
Valeria Paradies1, MD; Ori Ben-Yehuda2, MD; Michael Jonas3, MD; Shmuel Banai4, MD; Andres Iñiguez5, MD; Gidon Y. Perlman6, MD; David E. Kandzari7, MD; Gregg W. Stone2, MD; Pieter C. Smits1*, MD, PhD
1. Maasstad Hospital, Rotterdam, the Netherlands; 2. Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA; 3. Kaplan Medical Center, Rechovot, Israel; 4. Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 5. Ho
Aims: The aim of this study was to evaluate the efficacy and safety of the BioNIR stent compared with the Resolute Integrity stent for the treatment of coronary artery disease.